Derion F. Reid, Ph.D.
What you should know about me:
My background in Chemical Biology resonates deeply with D&M’s Chemical & Life Sciences practice group. I enjoy partnering with our dynamic clients who range from start-up organizations to universities and Fortune 500 corporations. I aim to provide clients the knowledge and unique IP strategies needed to advance their intellectual property portfolios.
- Known as a creative problem solver & approachable teammate
- Has baked most pastry recipes from the cookbook “Flour” by Chef Joanne Chang
- Solved the first crystal structure of NRAS (an oncogene commonly mutated in melanoma and other cancers)
Prior to joining D&M, Derion gained valuable experience working as a Patent Technology Specialist at Dana-Farber Cancer Institute, and other biotech startups. His education and industry-specific experience inspired a technical focus in sectors involving assay development, gene therapy, mRNAs, and DNA alteration techniques.
Derion takes an efficient and thoughtful approach in assisting clients with managing and procuring global IP protection in the life sciences and chemical arts. He works to collaborate and build an atmosphere of trust with his clients to ensure the mutual, proactive pursuit of desired outcomes.
Derion regularly assist in the drafting and prosecution of patent applications relating to medical devices, surgical and infection prevention products, drug delivery systems, pharmaceuticals, and similar subject matter.
Background & Credentials
- Winthrop University (B.S., Chemistry, 2014)
- Northeastern University (Ph.D., 2019)
- U.S. Patent and Trademark Office
- Clarity: The Speech, Hearing, and Learning Center (Board Member)
- Boston Patent Law Association
- Graduate Education for Minorites (GEM) Fellow
- Northeastern University Graduate Research Fellowship Recipient
- President, Northeastern University Chemistry Graduate Student Association
- Ronald E. McNair Scholar
- Reid, D. and Mattos, C., Cancer Therapy through a Structural Biology Perspective. Unraveling Cancer Signaling Pathways: A Multidisciplinary Approach. Springer, 2019.
- Johnson, C.W., Lin, Y.J., Reid, D., Parker, J., Pavlopoulos, S., Steensma, M., Haigis, K.M., and Mattos, C., Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D. Cell Reports, 28 (6), 1538-1550 (2019).
- *Reid, D., *Johnson, C.W., Parker, J.A., Salter, S., Knihtila, R., Kuzmic, P., and Mattos, C. The small GTPases K-Ras, N-Ras and H-Ras have distinct biochemical properties determined by allosteric effects. Journal of Biological Chemistry, 292 (31), 12981-12993 (2017). *co-first authors
- Sumter, T.F., Xian, L., Huso, T., Koo, M., Chang, Y.T., Almasri, T.N., Inglis, C., Reid, D., and Resar, L.M.S. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer & Development. Curr. Mol. Med., 16 (4), 353-393 (2016).
Looking for a change of pace?
D&M is committed to empowering employees with the right training, tools, and resources to reach their highest potential. Explore opportunities for every stage of your career.